CDER "transformation initiative" based on "proactive strategic focus" -- Woodcock.
This article was originally published in The Tan Sheet
Executive Summary
CDER "TRANSFORMATION INITIATIVE" FOCUSING ON STRATEGIC APPROACH TO REGULATION, is needed, FDA Center for Drug Evaluation & Research Director Janet Woodcock, MD, stated Sept. 30 at a Parenteral Drug Association/FDA joint conference in Washington, D.C. With FDA reform legislation put aside until next year, Woodcock underscored the need for internal FDA reform.